Most recently, it's been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to a big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger https://fredq986svx8.weblogco.com/profile